<?xml version="1.0" encoding="UTF-8"?>
<sec id="sec2-pharmaceuticals-10-00084" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">2. Results and Discussion</div>
 <p xmlns="http://www.w3.org/1999/xhtml">The essential oil of the aerial parts of 
  <span class="italic">Niphogeton dissecta</span> was obtained by steam distillation for 4 h, yielding an average of 0.33 ± 0.03% (
  <span class="italic">w</span>/
  <span class="italic">w</span>). The physical properties, chemical composition, enantiomeric analysis, and biological activity are discussed below.
 </p>
 <sec id="sec2dot1-pharmaceuticals-10-00084" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">2.1. Physical Properties</div>
  <p xmlns="http://www.w3.org/1999/xhtml">Three physical properties were determined: refractive index (
   <span class="italic">n</span> = 1.499 ± 0.002), relative density (
   <span class="italic">d</span> = 0.906 ± 0.012 g.m/L), and optical rotation (
   <div class="inline-formula">
    <div id="mm1" class="math">
     <div class="mrow">
      <div class="mrow">
       <div class="msubsup">
        <div class="mrow">
         <div class="mrow">
          <span class="mo">[</span>
          <span class="mo">∝</span>
          <span class="mo">]</span>
         </div>
        </div>
        <span class="mi">D</span>
        <div class="mrow">
         <span class="mn">20</span>
        </div>
       </div>
       <span class="mo">=</span>
       <span class="mo">−</span>
       <span class="mn">7.50</span>
       <span class="mo">±</span>
       <span class="mn">0.98</span>
      </div>
     </div>
    </div>
   </div> in CHCl
   <sub>3</sub>, c = 10.0). In this context, some authors state that the physical properties are determined by the genetic characteristics, geographical location, and phenological stages of the plant [
   <a rid="B16-pharmaceuticals-10-00084" ref-type="bibr" href="#B16-pharmaceuticals-10-00084">16</a>,
   <a rid="B17-pharmaceuticals-10-00084" ref-type="bibr" href="#B17-pharmaceuticals-10-00084">17</a>].
  </p>
 </sec>
 <sec id="sec2dot2-pharmaceuticals-10-00084" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">2.2. Chemical Composition</div>
  <p xmlns="http://www.w3.org/1999/xhtml">The chemical composition of the essential oil was defined based on calculated linear retention indices (LRIc) and mass spectra compared with literature [
   <a rid="B18-pharmaceuticals-10-00084" ref-type="bibr" href="#B18-pharmaceuticals-10-00084">18</a>,
   <a rid="B19-pharmaceuticals-10-00084" ref-type="bibr" href="#B19-pharmaceuticals-10-00084">19</a>,
   <a rid="B20-pharmaceuticals-10-00084" ref-type="bibr" href="#B20-pharmaceuticals-10-00084">20</a>,
   <a rid="B21-pharmaceuticals-10-00084" ref-type="bibr" href="#B21-pharmaceuticals-10-00084">21</a>,
   <a rid="B22-pharmaceuticals-10-00084" ref-type="bibr" href="#B22-pharmaceuticals-10-00084">22</a>,
   <a rid="B23-pharmaceuticals-10-00084" ref-type="bibr" href="#B23-pharmaceuticals-10-00084">23</a>]. 
   <a ref-type="table" rid="pharmaceuticals-10-00084-t001" href="#pharmaceuticals-10-00084-t001">Table 1</a> presents the components of the essential oil determined by GC-MS and quantified by GC-FID. Forty-one compounds were separated, which represented 96.46% of the total essential oil. The major compounds were acorenone B (41.01%), (E)-β-ocimene (29.64%), (3E)-butylidene phthalide (5.54%), and α-pinene (3.94%). Oxygenated sesquiterpenes (42.31%) and monoterpene hydrocarbons (37.97%) were the most representative groups. This is the first report on the characterization of the essential oil distilled from 
   <span class="italic">N. dissecta.</span>
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">A typical chromatogram of the essential oil from 
   <span class="italic">N. dissecta</span> is shown in 
   <a ref-type="fig" rid="pharmaceuticals-10-00084-f001" href="#pharmaceuticals-10-00084-f001">Figure 1</a>.
  </p>
 </sec>
 <sec id="sec2dot3-pharmaceuticals-10-00084" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">2.3. Isolation and Characterization of Acorenone B</div>
  <p xmlns="http://www.w3.org/1999/xhtml">Acorenone B was isolated by column chromatography on silica gel G60 (1 kg). The mixture (5.0 g) was eluted in isocratic condition with hexane-ethyl acetate 90:10. The compound (1.48 g) was obtained as a pale yellow oil, with optical rotation 
   <div class="inline-formula">
    <div id="mm2" class="math">
     <div class="mrow">
      <div class="mrow">
       <div class="msubsup">
        <div class="mrow">
         <div class="mrow">
          <span class="mo">[</span>
          <span class="mo">∝</span>
          <span class="mo">]</span>
         </div>
        </div>
        <span class="mi">D</span>
        <div class="mrow">
         <span class="mn">20</span>
        </div>
       </div>
       <span class="mo">=</span>
       <span class="mo">−</span>
       <span class="mn">17.6</span>
      </div>
     </div>
    </div>
   </div> (CHCl
   <sub>3</sub>; c = 11.4). Results similar to ours were reported by Zalkow [
   <a rid="B24-pharmaceuticals-10-00084" ref-type="bibr" href="#B24-pharmaceuticals-10-00084">24</a>].
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">The molecular structure of acorenone B (
   <a ref-type="fig" rid="pharmaceuticals-10-00084-f002" href="#pharmaceuticals-10-00084-f002">Figure 2</a>) was confirmed by 
   <span class="sup">1</span>H NMR, 
   <span class="sup">13</span>C NMR, and MS analysis, and compared with data present in the literature [
   <a rid="B24-pharmaceuticals-10-00084" ref-type="bibr" href="#B24-pharmaceuticals-10-00084">24</a>,
   <a rid="B25-pharmaceuticals-10-00084" ref-type="bibr" href="#B25-pharmaceuticals-10-00084">25</a>,
   <a rid="B26-pharmaceuticals-10-00084" ref-type="bibr" href="#B26-pharmaceuticals-10-00084">26</a>,
   <a rid="B27-pharmaceuticals-10-00084" ref-type="bibr" href="#B27-pharmaceuticals-10-00084">27</a>].
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">
   <span class="sup">1</span>H NMR (400 MHz, CDCl
   <sub>3</sub>), δ (ppm): 0.74 (3H, d, 
   <span class="italic">J</span> = 6.8 Hz, CH
   <sub>3</sub> of isopropyl), 0.83 (3H, d, 
   <span class="italic">J</span> = 6.8 Hz, CH
   <sub>3</sub> of isopropyl), 0.92 (3H, d, 
   <span class="italic">J</span> = 6.4 Hz, 4-CH
   <sub>3</sub>), 1.73 (3H, m, 8-CH
   <sub>3</sub>), 2.04 (1H, m, H-10), 2.20 (1H, m, H-6) 2.27 (1H, m, H-10), 2.67 (1H, m, H-6), 6.62 (1H, m, H-9).
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">
   <span class="sup">13</span>C NMR (100 MHz, CDCl
   <sub>3</sub>), δ (ppm): 200.6 (C-7), 144.4 (C-9), 135.4 (C-8), 56.9 (C-1), 49.4 (C-6), 48.4 (C-5), 46.1 (C-4), 29.8 (C-3), 29.2 (C-11), 26.0 (C-10), 25.3 (C-2), 24.2 (C-13), 21.4 (C-14), 17.1 (C-12), 15.6 (C-15).
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">EI-MS 
   <span class="italic">m</span>/
   <span class="italic">z</span> (%): 220 (M+, 58), 177 (76), 149 (45), 135 (100), 121 (60), 109 (100), 93 (46), 82 (84), 69 (28), 55 (22), 41 (29).
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">In our study, the fractionation of the essential oil of 
   <span class="italic">Niphogeton dissecta</span> afforded a pure sequiterpene: acorenone B. Several authors reported the occurrence of acorenone B in other volatile fractions, such as the ones of 
   <span class="italic">Bothriochloa intermedia</span> (47%) [
   <a rid="B24-pharmaceuticals-10-00084" ref-type="bibr" href="#B24-pharmaceuticals-10-00084">24</a>], 
   <span class="italic">Bothriochloa pertusa</span> (9.8%) [
   <a rid="B28-pharmaceuticals-10-00084" ref-type="bibr" href="#B28-pharmaceuticals-10-00084">28</a>], 
   <span class="italic">Chaerophyllum hirsutum</span> (9.47% to 18.49%) [
   <a rid="B26-pharmaceuticals-10-00084" ref-type="bibr" href="#B26-pharmaceuticals-10-00084">26</a>], 
   <span class="italic">Euphorbia macrorrhiza</span> (16.72% and 25.80%) [
   <a rid="B29-pharmaceuticals-10-00084" ref-type="bibr" href="#B29-pharmaceuticals-10-00084">29</a>], 
   <span class="italic">Levisticum persicum</span> (8.3% to 12.6%) [
   <a rid="B30-pharmaceuticals-10-00084" ref-type="bibr" href="#B30-pharmaceuticals-10-00084">30</a>], and as a major compound in 
   <span class="italic">Daucus littoralis subsp. Hyrcanicus</span> (19.7% to 57.5% in all parts) [
   <a rid="B31-pharmaceuticals-10-00084" ref-type="bibr" href="#B31-pharmaceuticals-10-00084">31</a>], and 
   <span class="italic">Bothriochloa bladhii</span> (18.2%) [
   <a rid="B32-pharmaceuticals-10-00084" ref-type="bibr" href="#B32-pharmaceuticals-10-00084">32</a>].
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">The occurrence of acorenone B in 
   <span class="italic">N. dissecta</span> oil appears somewhat unusual because of the diversity of the sesquiterpenoid skeleton involved. According to Zalkow et al. [
   <a rid="B24-pharmaceuticals-10-00084" ref-type="bibr" href="#B24-pharmaceuticals-10-00084">24</a>], the proposed structure of acorenone B is considered to be derived from 
   <span class="italic">trans</span>–
   <span class="italic">cis</span>-farnesol via the β-bisabolyl cation.
  </p>
 </sec>
 <sec id="sec2dot4-pharmaceuticals-10-00084" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">2.4. Enantiomeric Analysis</div>
  <p xmlns="http://www.w3.org/1999/xhtml">The enantiomeric distribution and enantiomeric excess (
   <span class="italic">e.e.</span>) (
   <a ref-type="table" rid="pharmaceuticals-10-00084-t002" href="#pharmaceuticals-10-00084-t002">Table 2</a>) of some chiral metabolites were determined on a cyclodextrine-based chiral stationary phase (MEGA-DEX-DET), comparing the retention time of separated enantiomers with enantiomerically pure standards. Two couples of chiral monoterpenoids were detected. The enantiomeric excesses of (+)-β-pinene and (+)-sabinene were quite considerable. These results further confirm that plants can also contain both enantiomers in the essential oil (
   <a ref-type="fig" rid="pharmaceuticals-10-00084-f003" href="#pharmaceuticals-10-00084-f003">Figure 3</a>).
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">It has been documented that sometimes different enantiomers may present dissimilar biological activities [
   <a rid="B33-pharmaceuticals-10-00084" ref-type="bibr" href="#B33-pharmaceuticals-10-00084">33</a>]. In our essential oil, the enantiomeric excess of (+)-β-pinene was 73.8% with respect to (–)-β-pinene. Some studies have shown that the positive enantiomer has antimicrobial activity against 
   <span class="italic">Candida albicans, Cryptococcus neoformans, Rhyzopus oryzae</span>, and methicillin-resistant 
   <span class="italic">Staphylococcus aureus</span> (MRSA) [
   <a rid="B34-pharmaceuticals-10-00084" ref-type="bibr" href="#B34-pharmaceuticals-10-00084">34</a>]. In contrast, the negative enantiomer exhibits antiviral properties against infectious bronchitis virus (IBV) [
   <a rid="B35-pharmaceuticals-10-00084" ref-type="bibr" href="#B35-pharmaceuticals-10-00084">35</a>].
  </p>
 </sec>
 <sec id="sec2dot5-pharmaceuticals-10-00084" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">2.5. Antimicrobial Activity</div>
  <p xmlns="http://www.w3.org/1999/xhtml">The essential oil showed a weak inhibitory activity against 
   <span class="italic">Enterococcus faecalis</span> and 
   <span class="italic">Staphylococcus aureus</span>, while acorenone B was non-active at the maximum dose tested (10 mg/mL) (
   <a ref-type="table" rid="pharmaceuticals-10-00084-t003" href="#pharmaceuticals-10-00084-t003">Table 3</a>). According to Holetz et al. [
   <a rid="B36-pharmaceuticals-10-00084" ref-type="bibr" href="#B36-pharmaceuticals-10-00084">36</a>], an antibacterial activity is considered good when the Minimal Inhibitory Concentration (MIC) value is less than 100 μg/mL, demonstrating that both the essential oil and acorenone B do not show inhibitory activity against the evaluated strains.
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">The weak antimicrobial activity can be explained by the abundance of oxygenated sesquiterpenes in the investigated essential oil. In fact, hydrocarbon sesquiterpenes [
   <a rid="B29-pharmaceuticals-10-00084" ref-type="bibr" href="#B29-pharmaceuticals-10-00084">29</a>], carvacrol, thymol, eugenol, perylaldehyde, cinnamaldehyde, and cinnamic acid [
   <a rid="B37-pharmaceuticals-10-00084" ref-type="bibr" href="#B37-pharmaceuticals-10-00084">37</a>] are compounds generally more efficient as antimicrobial inhibitors.
  </p>
 </sec>
 <sec id="sec2dot6-pharmaceuticals-10-00084" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">2.6. Cholinesterase Inhibition Test</div>
  <p xmlns="http://www.w3.org/1999/xhtml">In the present work, we also evaluated the anti-AChE and anti-BChE activities (
   <a ref-type="table" rid="pharmaceuticals-10-00084-t004" href="#pharmaceuticals-10-00084-t004">Table 4</a>). Acorenone B showed an inhibitory activity against AChE and BChE with IC
   <sub>50</sub> concentrations of 40.8 and 10.9 μg/mL, respectively (
   <a ref-type="fig" rid="pharmaceuticals-10-00084-f004" href="#pharmaceuticals-10-00084-f004">Figure 4</a>). These inhibitory potentials, even far from that of the reference compound donepezil (6.7 nM) versus AChE [
   <a rid="B38-pharmaceuticals-10-00084" ref-type="bibr" href="#B38-pharmaceuticals-10-00084">38</a>], are close to those previously published for galanthamine (2.2 µg/mL and 11.7 µg/mL) or other plant extracts [
   <a rid="B4-pharmaceuticals-10-00084" ref-type="bibr" href="#B4-pharmaceuticals-10-00084">4</a>,
   <a rid="B39-pharmaceuticals-10-00084" ref-type="bibr" href="#B39-pharmaceuticals-10-00084">39</a>,
   <a rid="B40-pharmaceuticals-10-00084" ref-type="bibr" href="#B40-pharmaceuticals-10-00084">40</a>]. Interestingly, in spite of its moderate inhibitory potential, galanthamine is a typical drug used for the treatment of Alzheimer's disease [
   <a rid="B41-pharmaceuticals-10-00084" ref-type="bibr" href="#B41-pharmaceuticals-10-00084">41</a>], validating our efforts to identify new potential inhibitory compounds. 
   <span class="italic">Niphogeton dissecta</span> essential oil exhibited selectivity for the inhibition of BChE, this property being particularly interesting in the treatment of Alzheimer's disease [
   <a rid="B40-pharmaceuticals-10-00084" ref-type="bibr" href="#B40-pharmaceuticals-10-00084">40</a>,
   <a rid="B42-pharmaceuticals-10-00084" ref-type="bibr" href="#B42-pharmaceuticals-10-00084">42</a>].
  </p>
 </sec>
</sec>
